Announcements Trials
Browse Landscape

Phase

Phase 2 33Phase 1/2 15Phase 1 11Phase NA 7Phase 3 4Phase 2/3 4Phase EARLY_PHASE1 2

Status

Completed 60Unknown 8Active not recruiting 8Recruiting 6Terminated 4

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 3Sarcoma 1Other solid neoplasm 1Genitourinary 1CNS 1

Conditions

Multiple Myeloma 2Wilms Tumor 1Retinoblastoma 1Recurrence 1Osteosarcoma 1Neuroblastoma 1Medulloblastoma 1Immunoglobulin Light-chain Amyloidosis 1Choroid Plexus Neoplasms 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Granulocyte Colony-Stimulating Factor × Clear all
NCT01987596 2020-10-29

Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer

Barbara Ann Karmanos Cancer Institute

Phase 3 Terminated
23 enrolled 9 charts
CNSGenitourinaryOther solid neoplasmSarcoma

Medulloblastoma, Wilms Tumor, Neuroblastoma, Recurrence, Retinoblastoma, Osteosarcoma, Choroid Plexus Neoplasms

NCT02489500 2018-09-10

VelRand

Boston Medical Center

Phase 3 Terminated
3 enrolled 11 charts
Plasma cell

Immunoglobulin Light-chain Amyloidosis

NCT00005834 2015-03-06

S9922 Combination Chemo Plus Filgrastim With or Without Thalidomide in Refractory Multiple Myeloma

SWOG Cancer Research Network

Phase 3 Terminated
19 enrolled
Plasma cell

Multiple Myeloma

NCT01301963 2014-08-06

Filgrastim With or Without Plerixafor in Treating Patients With Multiple Myeloma Previously Treated With Lenalidomide

Case Comprehensive Cancer Center

Phase 3 Terminated
9 enrolled 7 charts
Plasma cell

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡